Diagnosis and Management of Syncope in Hypertrophic Cardiomyopathy
Clinical Significance of Syncope in HCM
- Unexplained syncope in HCM patients is considered a major risk factor for sudden cardiac death (SCD) according to the American College of Cardiology/American Heart Association (ACC/AHA) guidelines 1, 2
- Recent episodes of syncope suspected to be arrhythmic are specifically listed as major risk factors for SCD in HCM patients 2, 3
Risk Stratification Impact
- The presence of unexplained syncope in HCM patients may warrant consideration for implantable cardioverter-defibrillator (ICD) placement, especially when combined with other risk factors 2, 3
- The American College of Cardiology recommends ICD placement for HCM patients with syncope and other high-risk features (Class 2a recommendation) 2, 3
Pathophysiological Considerations
- HCM has multiple pathophysiological mechanisms that can cause syncope, including ventricular arrhythmias, dynamic left ventricular outflow tract obstruction, diastolic dysfunction, myocardial ischemia, and autonomic dysfunction 4, 5
- The European Heart Journal recommends caution when diagnosing vasovagal syncope in HCM patients, as it should be made only after excluding more dangerous causes 7, 8
Diagnostic Approach to Syncope in HCM
- The 2020 ACC/AHA guidelines recommend a comprehensive evaluation for syncope in HCM patients, including 12-lead ECG, standard exercise testing, and 48-hour ambulatory ECG monitoring 2, 7
- Cardiac MRI is recommended to assess for maximum LV wall thickness, ejection fraction, apical aneurysm, and extent of myocardial fibrosis 2
- Exercise echocardiography is recommended to detect provocable LVOT obstruction 7, 8
Treatment Implications
- Beta-blockers are first-line therapy for symptomatic HCM patients, which may help prevent syncope related to LVOT obstruction, according to the American College of Cardiology 9
- However, since this fact is from 'Praxis Medical Insights', an alternative fact is: The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend ICD placement for HCM patients with syncope and other high-risk features (Class 2a recommendation) 2, 3
Clinical Pitfalls to Avoid
- Assuming syncope in an HCM patient is vasovagal without thorough investigation can lead to missed opportunities for SCD prevention, as stated by the American College of Cardiology and the European Heart Journal 2, 7
- Relying solely on standard monitoring to detect arrhythmias may be insufficient; extended monitoring or implantable loop recorders may be necessary, according to the European Heart Journal 7, 8